0001214659-22-005331.txt : 20220415
0001214659-22-005331.hdr.sgml : 20220415
20220415170035
ACCESSION NUMBER: 0001214659-22-005331
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220413
FILED AS OF DATE: 20220415
DATE AS OF CHANGE: 20220415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DS MED LLC
CENTRAL INDEX KEY: 0001845622
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40060
FILM NUMBER: 22830522
BUSINESS ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
STREET 2: SUITE 520
CITY: MIAMI
STATE: FL
ZIP: 33136
BUSINESS PHONE: 305-909-0840
MAIL ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
STREET 2: SUITE 520
CITY: MIAMI
STATE: FL
ZIP: 33136
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Longeveron Inc.
CENTRAL INDEX KEY: 0001721484
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472174146
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
STREET 2: SUITE 520
CITY: MIAMI
STATE: FL
ZIP: 33136
BUSINESS PHONE: 305-302-7158
MAIL ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
STREET 2: SUITE 520
CITY: MIAMI
STATE: FL
ZIP: 33136
FORMER COMPANY:
FORMER CONFORMED NAME: LONGEVERON LLC
DATE OF NAME CHANGE: 20171101
4
1
marketforms-55981.xml
PRIMARY DOCUMENT
X0306
4
2022-04-13
0001721484
Longeveron Inc.
LGVN
0001845622
DS MED LLC
1951 NW 7TH AVENUE
SUITE 520
MIAMI
FL
33136
false
false
true
false
Common Stock
2022-04-13
4
J
false
748694
0
D
7024208
D
Shares consist of Class B common stock (the "Class B Common Stock"), which is not registered under the Securities Exchange Act of 1934, as amended. Holders of Class B Common Stock have identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record. Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.
Shares distributed to members of DS Med, LLC, for no consideration.
/s/ Paul T. Lehr, attorney-in-fact
2022-04-15